A review of acute treatments for bipolar depression Silverstone, Peter H.; Silverstone, Trevor Silverstone, Peter H.; Silverstone, Trevor Less International Clinical Psychopharmacology. 19(3):113-124, May 2004. Abstract Abstract Favorite PDF Permissions Buy
The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care Romeo, Renee; Patel, Anita; Knapp, Martin; More Romeo, Renee; Patel, Anita; Knapp, Martin; Thomas, Christine Less International Clinical Psychopharmacology. 19(3):125-134, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Depression in the Italian community: epidemiology and socio-economic implications Battaglia, A.; Dubini, A.; Mannheimer, R.; More Battaglia, A.; Dubini, A.; Mannheimer, R.; Pancheri, P. Less International Clinical Psychopharmacology. 19(3):135-142, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Citalopram in the treatment of dysthymic disorder Hellerstein, David J.; Batchelder, Sarai; Miozzo, Ruben; More Hellerstein, David J.; Batchelder, Sarai; Miozzo, Ruben; Kreditor, David; Hyler, Steven; Gangure, Dinu; Clark, Joy Less International Clinical Psychopharmacology. 19(3):143-148, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder Lepola, Ulla; Wade, Alan; Andersen, Henning Friis Lepola, Ulla; Wade, Alan; Andersen, Henning Friis Less International Clinical Psychopharmacology. 19(3):149-155, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Relative sensitivity of the Montgomery–Åsberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis Khan, Arif; Brodhead, Amy E.; Kolts, Russell L. Khan, Arif; Brodhead, Amy E.; Kolts, Russell L. Less International Clinical Psychopharmacology. 19(3):157-160, May 2004. Abstract Abstract Favorite PDF Permissions Buy
A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use Jespersen, Sean; Berk, Michael; Wyk, Caren Van; More Jespersen, Sean; Berk, Michael; Wyk, Caren Van; Dean, Olivia; Dodd, Seetal; Szabo, Christopher P.; Maud, Catherine Less International Clinical Psychopharmacology. 19(3):161-164, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Efficacy of risperidone in treating the hyperactive symptoms of delirium Liu, Chia-Yih; Juang, Yeong-Yu; Liang, Hsin-Yi; More Liu, Chia-Yih; Juang, Yeong-Yu; Liang, Hsin-Yi; Lin, Ni-Chi; Yeh, Eng-Kun Less International Clinical Psychopharmacology. 19(3):165-168, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Quetiapine-induced diabetes with metabolic acidosis Meyer, Jonathan M.; Leckband, Susan G.; Loh, Catherine; More Meyer, Jonathan M.; Leckband, Susan G.; Loh, Catherine; Moutier, Christine Y. Less International Clinical Psychopharmacology. 19(3):169-171, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Use of quetiapine in bipolar disorder: a case series with prospective evaluation Suppes, T.; McElroy, S. L.; Keck, P. E.; More Suppes, T.; McElroy, S. L.; Keck, P. E.; Altshuler, L.; Frye, M. A.; Grunze, H.; Leverich, G. S.; Nolen, W. A.; Chisholm, K.; Dennehy, E. B.; Post, R. M. Less International Clinical Psychopharmacology. 19(3):173-174, May 2004. Abstract Abstract Favorite PDF Permissions Buy
Psychopharmacogenetic study regarding risperidone in Japanese schizophrenic patients Kakihara, Shingo; Yoshimura, Reiji; Matsumoto, Chima; More Kakihara, Shingo; Yoshimura, Reiji; Matsumoto, Chima; Kaji, Kyouko; Shinkai, Koji; Yamada, Yasuhisa; Goto, Makiko; Ueda, Nobuhisa; Ohmori, Osama; Nakamura, Jun Less International Clinical Psychopharmacology. 19(3):175, May 2004. Favorite PDF Permissions Buy
Clinical comparison of paroxetine and fluvoxamine considering of the serotonin transporter promoter polymorphism in patients with affective disorder Kato, Masaki; Wakeno, Masataka; Okugawa, Gaku; More Kato, Masaki; Wakeno, Masataka; Okugawa, Gaku; Nagata, Masahiro; Nobuhara, Kenji; Ochi, Tomoko; Ikenaga, Yuka; Fukuda, Tsuyoshi; Fukuda, Kazuhiro; Azuma, Junichi; Kinoshita, Toshihiko Less International Clinical Psychopharmacology. 19(3):175, May 2004. Favorite PDF Permissions Buy
Association between neuroleptic malignant syndrome and polymorphisms of the dopamine D2 receptor gene Kishida, Ikuko; Kawanishi, Chiaki; Furuno, Taku; More Kishida, Ikuko; Kawanishi, Chiaki; Furuno, Taku; Kato, Daiji; Kanai, Akiko; Yamada, Tomoki; Yamada, Yoshiteru; Hirayasu, Yoshio Less International Clinical Psychopharmacology. 19(3):175, May 2004. Favorite PDF Permissions Buy
The effects of 5-HT1A receptor gene polymorphism on clinical response to fluvoxamine Suzuki, Yutaro; Sawamura, Kazushi; Someya, Toshiyuki Suzuki, Yutaro; Sawamura, Kazushi; Someya, Toshiyuki Less International Clinical Psychopharmacology. 19(3):176, May 2004. Favorite PDF Permissions Buy
Neuroleptic malignant syndrome and genetic polymorphisms Kawanishi, Chiaki Kawanishi, Chiaki Less International Clinical Psychopharmacology. 19(3):176, May 2004. Favorite PDF Permissions Buy
Effects of olanzapine on quality of life in outpatients with schizophrenia Horikoshi, Ryu; Sugano, Keiju; Enguchi, Hiroshi; More Horikoshi, Ryu; Sugano, Keiju; Enguchi, Hiroshi; Nitsukuni, Shigeru; Sato, Koji; Ito, Mitsuhiro; Hoshino, Kenyo; Tsunoda, Koya; Suzuki, Yoshiaki; Shishido, Toshiaki; Honda, Kyoichi Less International Clinical Psychopharmacology. 19(3):176-177, May 2004. Favorite PDF Permissions Buy
Changes of patients' quality of life and relatives' expressed emotion after olanzapine treatment Horikoshi, Ryu; Matsuki, Motohiko; Takeuchi, Satoshi Horikoshi, Ryu; Matsuki, Motohiko; Takeuchi, Satoshi Less International Clinical Psychopharmacology. 19(3):177, May 2004. Favorite PDF Permissions Buy
Influence of the serotonin transporter gene polymorphism on therapeutic response and adverse effects of paroxetine in Japanese depressive patients Hirokane, G.; Morita, S.; Ueda, M.; More Hirokane, G.; Morita, S.; Ueda, M.; Okawa, M.; Shimoda, K. Less International Clinical Psychopharmacology. 19(3):177, May 2004. Favorite PDF Permissions Buy
Polymorphism of serotonin and histamine receptors and clinical efficacy of olanzapine Akimoto, T.; Morokawa, Y.; Kumai, T.; More Akimoto, T.; Morokawa, Y.; Kumai, T.; Sekiguchi, G.; Nakaya, S.; Suzuki, H.; Gen, K.; Kobayashi, S.; Aoba, A. Less International Clinical Psychopharmacology. 19(3):177-178, May 2004. Favorite PDF Permissions Buy
Plasma concentration of olanzapine and its clinical efficacy Sekiguchi, G.; Morokawa, Y.; Kumai, T.; More Sekiguchi, G.; Morokawa, Y.; Kumai, T.; Akimoto, T.; Nakaya, S.; Suzuki, H.; Gen, K.; Kobayashi, S.; Aoba, A. Less International Clinical Psychopharmacology. 19(3):178, May 2004. Favorite PDF Permissions Buy
Impact of CYP2D6 genotypes on the steady-state plasma concentrations of paroxetine in Japanese psychiatric patients Ueda, M.; Hirokane, G.; Morita, S.; More Ueda, M.; Hirokane, G.; Morita, S.; Okawa, M.; Shimoda, K. Less International Clinical Psychopharmacology. 19(3):178, May 2004. Favorite PDF Permissions Buy
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes Yasui-Furukori, Norio; Mihara, Kazuo; Takahata, Takenori; More Yasui-Furukori, Norio; Mihara, Kazuo; Takahata, Takenori; Suzuki, Akihito; Nakagami, Taku; De Vries, Ronald; Tateishi, Tomonori; Kondo, Tsuyoshi; Kaneko, Sunao Less International Clinical Psychopharmacology. 19(3):178-179, May 2004. Favorite PDF Permissions Buy
Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia Saito, Manabu; Yasui-Furukori, Norio; Mihara, Kazuo; More Saito, Manabu; Yasui-Furukori, Norio; Mihara, Kazuo; Miura, Jun; Inoue, Yoshimasa; Kondo, Tsuyoshi; Kaneko, Sunao Less International Clinical Psychopharmacology. 19(3):179, May 2004. Favorite PDF Permissions Buy
Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction Nakagami, Taku; Yasui-Furukori, Norio; Saito, Manabu; More Nakagami, Taku; Yasui-Furukori, Norio; Saito, Manabu; Mihara, Kazuo; De Vries, Ronald; Kondo, Tsuyoshi; Kaneko, Sunao Less International Clinical Psychopharmacology. 19(3):179, May 2004. Favorite PDF Permissions Buy
Small effects of low dosage levomepromazine on plasma risperidone levels in a steady state Yoshimura, Reiji; Shinkai, Koji; Kakihara, Shingo; More Yoshimura, Reiji; Shinkai, Koji; Kakihara, Shingo; Kaji, Kyoko; Yamada, Yasuhisa; Goto, Makiko; Ueda, Nobuhisa; Nakamura, Jun Less International Clinical Psychopharmacology. 19(3):180, May 2004. Favorite PDF Permissions Buy
Maintenance treatment with quetiapine in stable schizophrenic outpatients Miyamoto, Ayumu; Miyamae, Yasuyuki; Yanagi, Yuji Miyamoto, Ayumu; Miyamae, Yasuyuki; Yanagi, Yuji Less International Clinical Psychopharmacology. 19(3):180, May 2004. Favorite PDF Permissions Buy
Comparison of clinical evaluation and cognitive deficit before and after administration of risperidone to patients with schizophrenia Suzuki, Hidenobu; Morokawa, Yumiyo; Inoue, Yuichi; More Suzuki, Hidenobu; Morokawa, Yumiyo; Inoue, Yuichi; Gen, Keishi; Ishizeki, Kei; Takagi, Hiroyuki; Aoba, Anri Less International Clinical Psychopharmacology. 19(3):180, May 2004. Favorite PDF Permissions Buy
Dose reduction of antipsychotic agents ameliorates paroxysmal perceptual alteration: a controlled study Uchida, Hiroyuki; Nakajima, Shinichiro; Oka, Mizuki; More Uchida, Hiroyuki; Nakajima, Shinichiro; Oka, Mizuki; Suzuki, Takefumi; Watanabe, Koichiro; Yagi, Gohei; Kashima, Haruo Less International Clinical Psychopharmacology. 19(3):180-181, May 2004. Favorite PDF Permissions Buy
Anti-D2 and anti-5-HT2A activities of main metabolites of chlorpromazine Inoue, Y.; Morokawa, Y.; Onohara, A.; More Inoue, Y.; Morokawa, Y.; Onohara, A.; Sekiguchi, G.; Suzuki, H.; Gen, K.; Yanagida, H.; Uemura, M.; Yamaguchi, N.; Tanaka, A.; Aoba, A. Less International Clinical Psychopharmacology. 19(3):181, May 2004. Favorite PDF Permissions Buy
Relationships among daily dose of perospirone, concentrations of unchanged perospirone and active metabolite ID15036, anti-D2 activity, anti-5-HT2A activity and anti-5-HT2A activity/anti-D2 activity (S/D) ratio in plasma Miyake, N.; Morokawa, Y.; Sekiguchi, G.; More Miyake, N.; Morokawa, Y.; Sekiguchi, G.; Akimoto, T.; Suzuki, H.; Gen, K.; Ishizeki, K.; Kamimura, M.; Takagi, H.; Tanaka, A.; Aoba, A. Less International Clinical Psychopharmacology. 19(3):181, May 2004. Favorite PDF Permissions Buy
Effectiveness of herbal medicine and changes of quality of life in patients with somatoform disorders – the second report Yamada, K.; Den, R.; Ohnishi, K.; More Yamada, K.; Den, R.; Ohnishi, K.; Kanba, S. Less International Clinical Psychopharmacology. 19(3):181-182, May 2004. Favorite PDF Permissions Buy
How would dose-reduction affect schizophrenic patients taking high-dose of multiple neuroleptics? The first report: assessment of PANSS, DIEPSS, and ECG Kawai, Nobutoshi; Yamakawa, Yuriko; Matsuzaka, Hisashi; More Kawai, Nobutoshi; Yamakawa, Yuriko; Matsuzaka, Hisashi; Baba, Atsuomi; Tachikawa, Hirokazu; Hori, Takafumi; Asada, Takasi Less International Clinical Psychopharmacology. 19(3):182, May 2004. Favorite PDF Permissions Buy
Risperidone liquid is effective for patients with acute phase of schizophrenia Yoshimura, Reiji; Kakihara, Shingo; Shinkai, Koji; More Yoshimura, Reiji; Kakihara, Shingo; Shinkai, Koji; Kaji, Kyoko; Yamada, Yasuhisa; Goto, Makiko; Ueda, Nobuhisa; Nakamura, Jun Less International Clinical Psychopharmacology. 19(3):182, May 2004. Favorite PDF Permissions Buy
Actual trend of antipsychotic drug prescription at the Department of Psychiatry, St. Marianna University Hospital Gen, K.; Onohara, A.; Miyake, N.; More Gen, K.; Onohara, A.; Miyake, N.; Sekiguchi, G.; Akimoto, T.; Suzuki, H.; Kamimura, M.; Morokawa, Y.; Aoba, A. Less International Clinical Psychopharmacology. 19(3):182-183, May 2004. Favorite PDF Permissions Buy
A survey of atypical antipsychotics for schizophrenic out-patients treated in the university hospital Hara, Takashi; Ishikita, Hiroshi; Sakuma, Yuko; More Hara, Takashi; Ishikita, Hiroshi; Sakuma, Yuko; Igarashi, Masahumi; Akamoto, Tomoyasu; Haba, Atsushi; Takahashi, Shingo; Sugawara, Michiya Less International Clinical Psychopharmacology. 19(3):183, May 2004. Favorite PDF Permissions Buy
Simplifying psychotropic medication regimen into a single night dosing and reducing the dose for patients with chronic, stable schizophrenia Suzuki, Takefumi; Uchida, Hiroyuki; Den, Ryosuke; More Suzuki, Takefumi; Uchida, Hiroyuki; Den, Ryosuke; Watanabe, Koichiro; Yagi, Gohei; Kashima, Haruo Less International Clinical Psychopharmacology. 19(3):183, May 2004. Favorite PDF Permissions Buy
A trend toward monopharmacy in schizophrenia using atypical antipsychotics and its significance in a mental hospital Mitani, Marina; Yanagi, Kaori; Yamagichi, Syoko; More Mitani, Marina; Yanagi, Kaori; Yamagichi, Syoko; Arai, Hisatoshi; Kano, Akiko; Yoshioka, Masaya; Ichikawa, Toru; Hoshiya, Daijirou; Baba, Hiroko; Matsumi, Tatsutoshi; Ishigooka, Jun Less International Clinical Psychopharmacology. 19(3):183-184, May 2004. Favorite PDF Permissions Buy
A comparative prospective investigation of the efficacy and safety of the atypical antipsychotics in the treatment of schizophrenia: monotherapy by olanzapine, perospirone, quetiapine or risperidone compared with the old-style therapy by conventional antipsychotics Shirae, Hideko; Maru, Kanae; Uemura, Tomihiko; More Shirae, Hideko; Maru, Kanae; Uemura, Tomihiko; Hayakawa, Masaya; Tukahara, Atsuko; Yamamoto, Toshinori Less International Clinical Psychopharmacology. 19(3):184, May 2004. Favorite PDF Permissions Buy
Melperone, an atypical antipsychotic drug, in the treatment of schizophrenia: dose-response analysis on effectiveness and tolerability, and efficacy for treatment-resistant schizophrenia and cognitive function Sumiyoshi, Tomiki; Meltzer, Herbert Y.; Jayathilake, Karu Sumiyoshi, Tomiki; Meltzer, Herbert Y.; Jayathilake, Karu Less International Clinical Psychopharmacology. 19(3):184, May 2004. Favorite PDF Permissions Buy
Risperidone in the treatment of delusional depression Goto, Makiko; Yoshimura, Reiji; Kakihara, Shingo; More Goto, Makiko; Yoshimura, Reiji; Kakihara, Shingo; Yamada, Yasuhisa; Kaji, Kyoko; Shinkai, Koji; Ueda, Nobuhisa; Nakamura, Jun Less International Clinical Psychopharmacology. 19(3):184-185, May 2004. Favorite PDF Permissions Buy
Subjective effects of risperidone oral solution versus intramuscular haloperidol on agitated schizophrenic patients Shibata, Isao; Niwa, Shin-ichi Shibata, Isao; Niwa, Shin-ichi Less International Clinical Psychopharmacology. 19(3):185, May 2004. Favorite PDF Permissions Buy
Paroxetine augmentation of risperidone in a case of methamphetamine psychosis with obsessive–compulsive symptoms Taniguchi, K.; Kato, Y.; Okuda, J. Taniguchi, K.; Kato, Y.; Okuda, J. Less International Clinical Psychopharmacology. 19(3):185, May 2004. Favorite PDF Permissions Buy
A 32-case study where quetiapine therapy was continued following the issuance of a Dear Dr letter Oshimo, Takashi; Hatakoshi, Masataka; Ogawa, Kenji; More Oshimo, Takashi; Hatakoshi, Masataka; Ogawa, Kenji; Hashimoto, Kenji; Shirakawa, Osamu; Ohta, Masayuki; Maeda, Kiyoshi Less International Clinical Psychopharmacology. 19(3):185-186, May 2004. Favorite PDF Permissions Buy
The remission rate with milnacipran in the treatment of Japanese major depressive patients Higuchi, Hisashi; Yoshida, Keizo; Takahashi, Hitoshi; More Higuchi, Hisashi; Yoshida, Keizo; Takahashi, Hitoshi; Naito, Shingo; Kamata, Mitsuhiro; Ito, Kenichi; Sato, Kazuhiro Less International Clinical Psychopharmacology. 19(3):186, May 2004. Favorite PDF Permissions Buy
Clinical study of pharmacotherapy for double depression: 150 mg/day as the optimum dose of milnacipran Okumura, Kazuo Okumura, Kazuo Less International Clinical Psychopharmacology. 19(3):186, May 2004. Favorite PDF Permissions Buy
Augmentation effect of cabergoline to milnacipran in a case with refractory depression Shingo, Naito; Hisashi, Higuchi; Kazuhiro, Sato; More Shingo, Naito; Hisashi, Higuchi; Kazuhiro, Sato; Tetsuo, Shimizu; Takeshi, Inoue; Tsukasa, Koyama Less International Clinical Psychopharmacology. 19(3):186-187, May 2004. Favorite PDF Permissions Buy
A case with major depression showing marked tremor during treatments with amoxapine, paroxetine and diltiazem Miura, Jun; Shinohe, Yasuko; Morita, Nobuyuki; More Miura, Jun; Shinohe, Yasuko; Morita, Nobuyuki; Fujieda, Masaki; Yamazaki, Hiroshi; Kamataki, Tetsuya; Yasui-Furukori, Norio; Kaneko, Sunao Less International Clinical Psychopharmacology. 19(3):187, May 2004. Favorite PDF Permissions Buy
Severe adverse effects following selective serotonin reuptake inhibitor, paroxetine administration, hyponatremia, atrial fibrillation and delirium: case reports Morita, Sachiyo; Ichimura, Mai; Matsuo, Masahiro; More Morita, Sachiyo; Ichimura, Mai; Matsuo, Masahiro; Tanaka, Kazuhide; Hirokane, Genta; Ueda, Mikito; Okawa, Masako; Shimoda, Kazutaka Less International Clinical Psychopharmacology. 19(3):187, May 2004. Favorite PDF Permissions Buy
Two cases of abnormal sensation on eye movement associated with paroxetine discontinuation Wakeno, Masataka; Kato, Masaki; Okugawa, Gaku; More Wakeno, Masataka; Kato, Masaki; Okugawa, Gaku; Fukuda, Tsuyoshi; Ikenaga, Yuka; Azuma, Junichi; Kinoshita, Toshihiko Less International Clinical Psychopharmacology. 19(3):187-188, May 2004. Favorite PDF Permissions Buy
The effect of mianserin to tardive dyskinesia and dystonia Katena, Shino; Tsuji, Keiichiro; Nakajima, Toru; More Katena, Shino; Tsuji, Keiichiro; Nakajima, Toru; Terada, Satoshi; Inoue, Yuichi; Tajima, Osamu; Koga, Yoshihiko Less International Clinical Psychopharmacology. 19(3):188, May 2004. Favorite PDF Permissions Buy
Effectiveness of milnacipran for the treatment of chronic pain: a case report Kamata, Mitsuhiro; Naito, Shingo; Takahashi, Hitoshi; More Kamata, Mitsuhiro; Naito, Shingo; Takahashi, Hitoshi; Higuchi, Hisashi Less International Clinical Psychopharmacology. 19(3):188, May 2004. Favorite PDF Permissions Buy
Elevation of blood pressure induced by milnacipran Baba, Hiroko; Mitani, Marina; Matsumi, Tatsutoshi; More Baba, Hiroko; Mitani, Marina; Matsumi, Tatsutoshi; Ishigooka, Jun Less International Clinical Psychopharmacology. 19(3):188-189, May 2004. Favorite PDF Permissions Buy
The effects of drug-treatment on personality features measured by TCI in panic disorder Nitta, Mari; Kusunoki, Kazunori; Abe, Tokuichiro; More Nitta, Mari; Kusunoki, Kazunori; Abe, Tokuichiro; Takeichi, Sachiko; Narita, Tomohiro; Ozaki, Norio Less International Clinical Psychopharmacology. 19(3):189, May 2004. Favorite PDF Permissions Buy
The molecular pharmacogenetic study of clinical effects and adverse effects of perospirone–preliminary report Sawamura, Kazushi; Suzuki, Yutaro; Someya, Toshiyuki Sawamura, Kazushi; Suzuki, Yutaro; Someya, Toshiyuki Less International Clinical Psychopharmacology. 19(3):189, May 2004. Favorite PDF Permissions Buy
Phenytoin intoxication following coadministration of clobazam in the patient with cytochrome P450(CYP)2C19*1/*3 genotype. A case report Morita, Sachiyo; Hirokane, Genta; Ueda, Mikito; More Morita, Sachiyo; Hirokane, Genta; Ueda, Mikito; Okawa, Masako; Shimoda, Kazutaka Less International Clinical Psychopharmacology. 19(3):189, May 2004. Favorite PDF Permissions Buy
Effects of the CYP2C19 genotype and cigarette smoking on the single oral dose pharmacokinetics and pharmacodynamics of estazolam Aoshima, Toshiaki; Fukasawa, Takashi; Otsuji, Yohei; More Aoshima, Toshiaki; Fukasawa, Takashi; Otsuji, Yohei; Okuyama, Naoyuki; Gerstenberg, Gisa; Miura, Masatomo; Ohkubo, Tadashi; Sugawara, Kazunobu; Otani, Koichi Less International Clinical Psychopharmacology. 19(3):190, May 2004. Favorite PDF Permissions Buy
Establishment of new cloned enzyme donor immunoassays (CEDIA®) for haloperidol and bromperidol Furukori, Hanako; Yasui-Furukori, Norio; Saito, Manabu; More Furukori, Hanako; Yasui-Furukori, Norio; Saito, Manabu; Inoue, Yoshimasa; Someya, Toshiyuki; Kaneko, Sunao; Tateishi, Tomonori Less International Clinical Psychopharmacology. 19(3):190, May 2004. Favorite PDF Permissions Buy
Pharmacology of aripiprazole, a novel antipsychotic: dopamine D2 receptor partial agonist Kikuchi, Tetsuro; Arlene, Stark; Yocca, Frank; More Kikuchi, Tetsuro; Arlene, Stark; Yocca, Frank; Tadori, Yoshihiro; Hirose, Tsuyoshi; McQuade, Robert Less International Clinical Psychopharmacology. 19(3):190, May 2004. Favorite PDF Permissions Buy
